← FDA DRUG APPROVALS

FDA ANDA · ANDA071184

THIOTHIXENE HYDROCHLORIDE

Sponsor: TEVA

APPLICATION
ANDA071184
TYPE
ANDA
ORIGINAL APPROVAL
1987-06-22
LATEST ACTION
2001-08-30
ROUTE
ORAL
DOSAGE FORM
CONCENTRATE
MARKETING STATUS
Discontinued

Products

THIOTHIXENE HYDROCHLORIDEDiscontinued
THIOTHIXENE HYDROCHLORIDE EQ 5MG BASE/ML · CONCENTRATE · ORAL

Approval history

2001-08-30Manufacturing (CMC) · Supplement 5AP
1991-03-04Labeling · Supplement 4AP
1989-02-28Manufacturing (CMC) · Supplement 3AP
1988-09-07Labeling · Supplement 2AP
1987-06-22OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →